#Venetoclax

Elizabeth McKenna

ElizSMcKenna

In honor of the Ham-Wasserman Lecture by Andrew Roberts at #ASH20, I'd like to share some of the key #venetoclax content published in @CD_AACR over the past few years: From

Catherine Smith, MD

SmithLabSF

Be still my heart, you know I love me some drug resistance talks! Session 604 was! Some highlights. THREAD. #ASH20 #ASHFromHome #ASHtogether #leusm #ImaHemeDork. 1)First up, on target resistance wins

Samer Al Hadidi, MD MSc

HadidiSamer

#TCTM21 Plenary: Leukemia: Drugs to Decrease Relapse Dr DiNardo @LeukemiaMDA AML prognosis depends on genetics, nice treatment algorithm Core-binding factor AML (inv (16) or t (8,21) : GO added to

Amer Zeidan, MBBS, MHS

Dr_AmerZeidan

1) Gearing up for a series of #ASH20 highlights in #AMLsm and #MDSsm and will post threads about main highlights on major topics starting with TP53-mutated AML. This subset of

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.